FTC sues big pharmacy advantage administrators over insulin costs The agency brought action versus Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing cost of lifestyle-preserving insulin medication. You should not skip tomorrow's healthcare field news Allow Healthcare Dive's totally free newsletter https://labelthefigurewiththeitem27161.snack-blog.com/30613321/everything-about-healthcare-news